Dupilumab: Mechanism of action, clinical, and translational science
Abstract Allergic disease prevalence has increased globally with the subset of type 2 inflammatory diseases playing a substantial role. Type 2 inflammatory diseases may differ in clinical presentation, but they exhibit shared pathophysiology that is targeted by the unique pharmacology of dupilumab....
Saved in:
Main Authors: | Marc R. McCann (Author), Matthew P. Kosloski (Author), Christine Xu (Author), John D. Davis (Author), Mohamed A. Kamal (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Upadacitinib: Mechanism of action, clinical, and translational science
by: Mohamed‐Eslam F. Mohamed, et al.
Published: (2024) -
Molnupiravir: Mechanism of action, clinical, and translational science
by: Brian M. Maas, et al.
Published: (2024) -
Momelotinib: Mechanism of action, clinical, and translational science
by: Georgios Vlasakakis, et al.
Published: (2024) -
Mobocertinib: Mechanism of action, clinical, and translational science
by: Michael J. Hanley, et al.
Published: (2024) -
Maribavir: Mechanism of action, clinical, and translational science
by: Kefeng Sun, et al.
Published: (2024)